CAMBRYN BIOLOGICS ANNOUNCES COMPLETION OF CONTRACT DEVELOPMENT MANUFACTURING AGREEMENT AND FILING OF PATENT

SARASOTA, Florida – September 5, 2016, Mark P. Famiglio, CEO of Cambryn Biologics, a privately held Delaware corporation, announces that the Company has added additional scientific staff to complete the development of two plasma derived therapeutic products announces earlier in February of this year

The additional staff consist Dr. Sarah CONNER PhD, responsible for the analytical development, along with Michael GAZZIA a senior biochemist, Adam Armengol biologist and Aaron Adderley, a biomedical engineer, Stephanie Wolfrom laboratory technologist and Christina Bostrom in Quality Assurance Documentation.  A new microbiologist is scheduled to join the team on January 5, 2017.  

“The addition of these individuals will significantly enhance our research and development capabilities” said Mark Famiglio. 

About Cambryn

Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies, advanced wound healing and biosurgical hemostats. The Company specializes in the extraction and purification of human plasma proteins. Cambryn operates a 50,000 square foot state-of-the-art cGMP facility, which incorporates cleanrooms and laboratories.

For additional information contact:
Cambryn Biologics LLC
Mark P. Famiglio
Chief Executive Officer
600 Tallevast Rd – Suite 201
Sarasota, Florida USA 34243
Office: 941-355-7400
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.cambrynbiologics.com

Cambryn Biologics LLC

Cambryn Biologics LLC is a Delaware corporation having its principal facility and offices in Sarasota, Florida. Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies.

logo small

State-of-the-Art Manufacturing Facility

Our facility consists of 50,000 square feet, located adjacent to the Sarasota/Bradenton International Airport, Sarasota, Florida, USA. Cambryn Biologics operates a state-of-the-art manufacturing facility.

Contact Details

Address: 600 Tallevast Rd.
Suite 201 Sarasota, FL 34243

Phone: (941) 355-7400

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.